Melguizo Alonso, Consolación Author
MMR-proficient and MMR-deficient colorectal cancer cells: 5-Fluorouracil treatment response and correlation to CD133 and MGMT expression
- Oliver J.A.
- Ortiz R.
- Jiménez-Luna C.
- Cabeza L.
- Perazzoli G.
- Caba O.
- Mesas C.
- Melguizo C.
- Prados J.
Journal of Biosciences - 1/12/2020
- JCR Quartile: Q3 (2020)
- JCR Impact Factor: 1.826 (2023)
- Category normalized Impact: 0.144 (2020)
- CiteScore: 2.1 (2020)
- SJR: 0.459 (2020
- SNIP: 0.489 (2020
- JCR 5-year Impact Factor: 2.107
- JCR Categories: BIOLOGY
- Scopus
- ORCID
- Web of Science
Microenvironmental modulation of decorin and lumican in temozolomide-resistant glioblastoma and neuroblastoma cancer stem-like cells
- Farace C.
- Oliver J.A.
- Melguizo C.
- Alvarez P.
- Bandiera P.
- Rama A.R.
- Malaguarnera G.
- Ortiz R.
- Madeddu R.
- Prados J.
PLoS One - 31/7/2015
- SJR Quartile: Q1
- JCR Impact Factor: 3.057 (2015)
- CiteScore: 5.3 (2020)
- SJR: 1.427 (2015
- SNIP: 1.16 (2015
- JCR 5-year Impact Factor: 3.535
- JCR Categories: MULTIDISCIPLINARY SCIENCES
- SJR Categories: Agricultural and Biological Sciences (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1)
- Scopus
- ORCID
- Web of Science
MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
- Melguizo C.
- Prados J.
- González B.
- Ortiz R.
- Concha A.
- Alvarez P.
- Madeddu R.
- Perazzoli G.
- Oliver J.
- López R.
- Rodríguez-Serrano F.
- Aránega A.
Journal of Translational Medicine - 17/12/2012
- SJR Quartile: Q1
- JCR Impact Factor: 3.459 (2012)
- CiteScore: 4.22 (2018)
- SJR: 1.547 (2012
- SNIP: 1.039 (2012
- JCR 5-year Impact Factor: 3.864
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
- SJR Categories: Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1)
- Scopus
- ORCID
- Web of Science
Methodology in the European higher education area for the Anatomy learning in the Health Sciences
- Prados, J.
- Melguizo, C.
- Rodriguez-Serrano, F.
- Velez, C.
- Hita, F.
- Peran, M.
- Boulaiz, H.
- Caba, O.
- Ortiz, R.
- Martinez, A.
- Marchal, J. A.
- Carrillo, E.
- Alvarez, L.
- Aranega, A.
European Journal of Anatomy - 1/10/2007
- SJR Quartile: Q4
- Category normalized Impact: 0.145 (2007)
- CiteScore: 0.5 (2020)
- SJR: 0.128 (2007
- SNIP: 0.257 (2007
- SJR Categories: Anatomy (Q4)
- Scopus
- ORCID
- Web of Science
Meroxest improves the prognosis of immunocompetent C57BL/6 mice with allografts of E0771 mouse breast tumor cells
- Carrasco, Esther
- Manuel Garrido, Jose
- Juan Alvarez, Pablo
- Alvarez-Manzaneda, Enrique
- Chahboun, Rachid
- Messouri, Ibtissam
- Melguizo, Consolacion
- Aranega, Antonia
- Rodriguez-Serrano, Fernando
Archives of Medical Science - 1/10/2016
- SJR Quartile: Q2
- JCR Impact Factor: 1.969 (2016)
- CiteScore: 5 (2020)
- SJR: 0.79 (2016
- SNIP: 0.994 (2016
- JCR 5-year Impact Factor: 1.904
- JCR Categories: MEDICINE, GENERAL & INTERNAL
- SJR Categories: Medicine (miscellaneous) (Q2)
- Scopus
- ORCID
- Web of Science
MDR1 gene expression in peripheral blood as a marker of treatment response in lung cancer
- Luque, Raquel
- Gonzalez Flores, Encarnacion
- Ramon Delgado, Juan
- Melguizo, Consolacin
- Carlos Prados, Jose
- Gonzalez Astorga, Beatriz
- Ortiz, Raul
- Sanchez Toro, Carmen
- Valdivia, Javier
- Aranega, Antonia
JOURNAL OF CLINICAL ONCOLOGY - 20/10/2012
10.1200/jco.2012.30.30_suppl.96
- SJR Quartile: Q1
- JCR Impact Factor: 18.038 (2012)
- JCR 5-year Impact Factor: 17.255
- JCR Categories: ONCOLOGY
- SJR Categories: Cancer Research (Q1); Medicine (miscellaneous) (Q1); Oncology (Q1)
Mdr1 gene expression as a marker of treatment response in non-small cell lung cancer (NSCLC)
- Luque, R.
- Melguizo, C.
- Gonzalez, E.
- Prados, J. C.
- Martinez, J.
- Rama, A.
- Valdivia, J.
- Ortiz, R.
- Conde, V.
- Delgado, J. R.
JOURNAL OF CLINICAL ONCOLOGY - 20/05/2010
10.1200/jco.2010.28.15_suppl.e13151
- SJR Quartile: Q1
- JCR Impact Factor: 18.97 (2010)
- JCR 5-year Impact Factor: 16.429
- JCR Categories: ONCOLOGY
- SJR Categories: Cancer Research (Q1); Medicine (miscellaneous) (Q1); Oncology (Q1)
Magnetic solid lipid nanoparticles in hyperthermia against colon cancer
- Muñoz de Escalona M.
- Sáez-Fernández E.
- Prados J.
- Melguizo C.
- Arias J.
INTERNATIONAL JOURNAL OF PHARMACEUTICS - 17/5/2016
- SJR Quartile: Q1
- JCR Impact Factor: 3.649 (2016)
- CiteScore: 8.6 (2020)
- SJR: 1.323 (2016
- SNIP: 1.383 (2016
- JCR 5-year Impact Factor: 4.224
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Pharmaceutical Science (Q1)
- Scopus
- ORCID
- Web of Science
Magnetically active pNIPAM nanosystems as temperature-sensitive biocompatible structures for controlled drug delivery
- Garcia-Pinel B.
- Ortega-Rodríguez A.
- Porras-Alcalá C.
- Cabeza L.
- Contreras-Cáceres R.
- Ortiz R.
- Díaz A.
- Moscoso A.
- Sarabia F.
- Prados J.
- López-Romero J.M.
- Melguizo C.
Artificial Cells Nanomedicine and Biotechnology - 1/1/2020
- JCR Quartile: Q1 (2020)
- JCR Impact Factor: 5.678 (2022)
- Category normalized Impact: 1.322 (2020)
- CiteScore: 8.3 (2020)
- SJR: 0.935 (2020
- SNIP: 1.163 (2020
- JCR 5-year Impact Factor: 5.246
- JCR Categories: MATERIALS SCIENCE, BIOMATERIALS
- Scopus
- ORCID
- Web of Science
The story of a doctoral thesis: GEF, a new gene with applications in anti-tumor gene therapy
- Boulaiz, H
- Prados, J
- Melguizo, C
- Marchal, JA
- Carrillo, E
- Velez, C
- Fernandez, JE
- Alvarez, L
- Caba, O
- Aranega, A
CELLULAR AND MOLECULAR BIOLOGY - 06/2003
- JCR Quartile: Q4 (2003)
- SJR Quartile: Q1
- JCR Impact Factor: 1.153 (2022)
- SJR Categories: Medicine (miscellaneous) (Q1)
Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy
- Marchal J.
- García M.
- Boulaiz H.
- Perán M.
- Álvarez P.
- Prados J.
- Melguizo C.
- Aránega A.
Stem Cells and Cancer Stem Cells, Volume 3: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 3 - 1/1/2012
- Scopus
- ORCID
This author has no conferences.
This author has no patents.
Synthesis, solubility and antitumor activity of maslinic acid derivatives
- Fuentes-Rios, D.
- Cepero, A.
- Garcia-Castro, M.
- Contreras-Caceres, R.
- Lopez-Romero, J. M.
- Luque, C.
- Cabeza, L.
- Melguizo, C.
- Prados, J.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS - 4/2022
Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review
- Lidia Gago
- Francisco Quiñonero
- Gloria Perazzoli
- Consolacion Melguizo
- Jose Prados
- Raul Ortiz
- Laura Cabeza
Pharmaceutics - 13/06/2023
- Scopus
- ORCID
- Web of Science
Downregulated microRNAs in the colorectal cancer: Diagnostic and therapeutic perspectives
- Hernández R.
- Sánchez-Jiménez E.
- Melguizo C.
- Prados J.
- Rama A.R.
BMB Reports - 1/1/2018
- SJR Quartile: Q1
- JCR Impact Factor: 2.966 (2018)
- CiteScore: 6 (2020)
- SJR: 1.082 (2018
- SNIP: 0.952 (2018
- JCR 5-year Impact Factor: 2.838
- JCR Categories: BIOCHEMISTRY & MOLECULAR BIOLOGY
- SJR Categories: Medicine (miscellaneous) (Q1); Biochemistry (Q2); Molecular Biology (Q2)
- Scopus
- ORCID
- Web of Science
Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Cancer Gene Therapy, (2019), 10.1038/s41417-019-0137-3)
- Ballesteros A.
- Hernández R.
- Perazzoli G.
- Cabeza L.
- Melguizo C.
- Vélez C.
- Prados J.
CANCER GENE THERAPY - 1/1/2020
- JCR Impact Factor: 5.987 (2020)
- CiteScore: 8.1 (2020)
- SJR: 1.535 (2020
- SNIP: 1.113 (2020
- JCR 5-year Impact Factor: 5.358
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
Contact info
Email: melguizo@ual.es
h index
Scopus: 27
Web of Science: 30
i10 index
Scopus: 78
Web of Science: 90
Author profiles
-
ORCID
-
Web of Science ResearcherID
-
Scopus Author ID
-
Dialnet id
Research projects at UAL
-
Acronym CV20-78799Since: September 8, 2020Until: September 7, 2021Funded by: JUNTAFunding / grant amount: 60,000.00 EURRole: Investigador